ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.
about
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) familyBiosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanaseGene expression programs of mouse endothelial cells in kidney development and disease.A new Adamts9 conditional mouse allele identifies its non-redundant role in interdigital web regression.Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesisPericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysisADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and RotationAnalysis of uterine gene expression in interleukin-15 knockout mice reveals uterine natural killer cells do not play a major role in decidualization and associated angiogenesisADAMTS-18 in the host tissues exerts little effect on breast tumor progress in a murine 4T1 breast cancer modelAnti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.Diabetes genes identified by genome-wide association studies are regulated in mice by nutritional factors in metabolically relevant tissues and by glucose concentrations in islets.Emerging Roles of ADAMTSs in Angiogenesis and Cancer.Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.Altered gene expression in dry age-related macular degeneration suggests early loss of choroidal endothelial cellsMatricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.The murine allantois: a model system for the study of blood vessel formation.Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor.The roles of ADAMTS in angiogenesis and cancer.Genetic and biochemical evidence that gastrulation defects in Pofut2 mutants result from defects in ADAMTS9 secretion.ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice.ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation.Differentially regulated ADAMTS1, 8, 9, and 18 in pancreas adenocarcinoma.Molecular Fingerprint for Terminal Abdominal Aortic Aneurysm Disease.Molecular Regulation of Sprouting Angiogenesis.ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2.ADAMTS9-Regulated Pericellular Matrix Dynamics Governs Focal Adhesion-Dependent Smooth Muscle Differentiation.Parallel Genome-wide Profiling of Coding and Non-coding RNAs to Identify Novel Regulatory Elements in Embryonic and Maturated Heart.Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15ADAMTS9locus associates with increased risk of wet AMD
P2860
Q21146633-7F484698-CF82-4C70-BDC7-D319B6CF2013Q28594757-8C15A7A9-C7C7-42C3-9D82-DEC617EFADBFQ33656631-046E9DC3-6656-45E0-A815-9A78481D6E6DQ33934134-577C0F78-A708-4B40-937D-D6CF82A8ED47Q33959044-23DED63A-ED36-4B94-B8F7-189F204F26D8Q35310907-E773E940-D85D-431D-A5F9-3E37FA628FC0Q35756427-4ECB23D8-DCA7-4F41-9EDA-C656C3D89582Q35840453-E4A743C4-16DC-4F59-AF0D-B48D0B31CABFQ36538502-D0FE1D8F-2694-4646-868F-7B8039403E13Q36601451-798B43A6-190F-4743-B8B6-E64D3B3B24CCQ36877444-854653E4-0232-4300-8611-6CA7729A4B76Q37017089-CE6A843F-2325-45CB-9238-0A8E70B0B0F3Q37298462-552178F4-0312-461B-B738-5ED2A534EDBEQ37326922-50E401A5-0B1A-443C-87F1-866507147E69Q37395835-878DAE33-C457-4617-BBE5-95C28512E56CQ37641594-B5466E37-EFDD-4CD4-9329-348C0992F127Q38031457-5121D50B-9BF8-4E2E-851B-E7E5F5E8A003Q38322817-A541C337-2691-4C27-B77F-7A20E2288995Q38444312-0CCD5AA0-0B80-4848-8F7C-A012F5262098Q38764647-4079F6F6-EA64-4EF9-BE67-641051B250A1Q39210448-5032BC0D-6801-4ACC-A376-70E9C4B16339Q39294227-A8A967FB-42A5-4311-B97D-8FA60C205BF7Q41977047-29387864-65AB-4B67-8E69-70DDFB37CEDBQ49305726-B2E66BF2-3505-445E-9B64-030AEDCE577BQ49388248-50A8CECA-C69C-4F77-9E1E-A577BBE9D8F6Q50423780-0004DB45-375E-4111-A40B-E6859142B268Q50654032-0CFC21EC-E1F0-4BF2-8836-AA0930BFC86AQ52720043-EAF36FD0-D0F7-427F-ADBD-05DE77CD8EC9Q55405827-DDD315AD-2074-41B2-9A12-49885DE0349DQ58211645-F38FFD92-E021-4E71-9C46-60E518352805Q58325370-C8EB6668-0AE2-48B5-904C-9C1C35487117
P2860
ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
ADAMTS9 is a cell-autonomously ...... crovascular endothelial cells.
@ast
ADAMTS9 is a cell-autonomously ...... crovascular endothelial cells.
@en
type
label
ADAMTS9 is a cell-autonomously ...... crovascular endothelial cells.
@ast
ADAMTS9 is a cell-autonomously ...... crovascular endothelial cells.
@en
prefLabel
ADAMTS9 is a cell-autonomously ...... crovascular endothelial cells.
@ast
ADAMTS9 is a cell-autonomously ...... crovascular endothelial cells.
@en
P2093
P2860
P1476
ADAMTS9 is a cell-autonomously ...... crovascular endothelial cells.
@en
P2093
Bon-Hun Koo
Courtney M Nelson
Daniel J Lindner
David M Coe
Laura J Dixon
Lauren W Wang
Mary Elizabeth Young
Robert P T Somerville
Suneel S Apte
P2860
P304
P356
10.2353/AJPATH.2010.090655
P407
P577
2010-01-21T00:00:00Z